Development of High-throughput and Robust Microfluidic Live Cell Assay Platforms for Combination Drug and Toxin Screening
Combination chemotherapies that introduce multi-agent treatments to target cancer cells are emerging as new paradigms to overcome chemotherapy resistance and side effects involved with conventional monotherapies. In environmental toxicology, characterizing effects of mixtures of toxins rather than...
Main Author: | Wang, Han |
---|---|
Other Authors: | Han, Arum |
Format: | Others |
Language: | en_US |
Published: |
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/1969.1/ETD-TAMU-2011-12-10517 |
Similar Items
-
Microfluidic Devices for Drug Assays
by: Clément Regnault, et al.
Published: (2018-06-01) -
High-Throughput Incubation and Quantification of Agglutination Assays in a Microfluidic System
by: David Castro, et al.
Published: (2018-06-01) -
High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform)
by: Dohyun Park, et al.
Published: (2019-05-01) -
Cord-Based Microfluidic Chips as A Platform for ELISA and Glucose Assays
by: Jenny Elomaa, et al.
Published: (2019-09-01) -
A Flexible, Microfluidic, Dispensing System for Screening Drug Combinations
by: Mark Davies, et al.
Published: (2020-10-01)